Publication | Open Access
Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide
277
Citations
25
References
2007
Year
Our large, multicenter trial showed that the non-stem-cell toxic DRC regimen is an active, well-tolerated treatment for symptomatic patients with WM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1